Sai Life Sciences Board of Directors
Get the latest insights into the leadership at Sai Life Sciences. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Dr. Kanumuri Ranga Raju | Chairman & Wholetime Director |
| Mr. Krishnam Raju Kanumuri | Managing Director & CEO |
| Mr. Mitesh Daga | Non Exe. & Nominee Director |
| Mr. Rajagopal Srirama Tatta | Independent Director |
| Mr. Ramesh Ganesh Iyer | Independent Director |
| Ms. Suchita Sharma | Independent Director |
Sai Life Sciences Share price
SAILIFE
845.1
20.40 (2.47%)NSE
BSE
Last updated on 1 Sep, 2025 | 15:43 IST
BUYSELL
Today's High
847.70
Today's Low
827.10
52 Week Low
636.10
52 Week High
943.00
The current prices are delayed, login to your account for live prices
LoginSai Life Sciences FAQs
The board at Sai Life Sciences consists of experienced professionals, including Dr. Kanumuri Ranga Raju , Mr. Krishnam Raju Kanumuri , and others, overseeing the company’s strategic and corporate governance.
Directors at Sai Life Sciences are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Dr. Kanumuri Ranga Raju is the current chairman at Sai Life Sciences.
Executive directors at Sai Life Sciences are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Sai Life Sciences adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Sai Life Sciences, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.